Cephalon Hit With FCA Suit Over Off-Label Marketing
Cephalon Inc. was hit with a whistleblower suit in New York federal court Friday claiming the drugmaker submitted hundreds of thousands of false claims to federal and state health care programs...To view the full article, register now.
Already a subscriber? Click here to view full article